<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1145072</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Development and validation of a flow cytometry antibody test for <italic>Lawsonia intracellularis</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Baldasso</surname>
<given-names>D&#xe9;bora Zini</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2178252"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guizzo</surname>
<given-names>Jo&#xe3;o Ant&#xf4;nio</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2220337"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dazzi</surname>
<given-names>Cl&#xe1;udia Cerutti</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/899917"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paraboni Frandoloso</surname>
<given-names>Gabriela Carolina</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1115255"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feronato</surname>
<given-names>C&#xe9;sar</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2239412"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>von Berg</surname>
<given-names>Stephan</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2174099"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carvalho Guedes</surname>
<given-names>Roberto Maur&#xed;cio</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1331149"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilson</surname>
<given-names>Heather Lynne</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/142939"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kreutz</surname>
<given-names>Luiz Carlos</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/874542"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Frandoloso</surname>
<given-names>Rafael</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/881845"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Laboratory of Microbiology and Advanced Immunology, Faculty of Veterinary Medicine, University of Passo Fundo</institution>, <addr-line>Passo Fundo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Section of Immunology, AFK Imunotech</institution>, <addr-line>Passo Fundo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Swine Technical Department, Merck Sharp &amp; Dohme (MSD)</institution>, <addr-line>S&#xe3;o Paulo</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Global Marketing Swine, Merck Sharp &amp; Dohme (MSD), Animal Health</institution>, <addr-line>Munich</addr-line>, <country>Germany</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Veterinary Clinic and Surgery, Veterinary School, Universidade Federal de Minas Gerais</institution>, <addr-line>Belo Horizonte</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan</institution>, <addr-line>Saskatoon, SK</addr-line>, <country>Canada</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Felix Ngosa Toka, Ross University School of Veterinary Medicine, Saint Kitts and Nevis</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Eduardo Ruben Cobo, University of Calgary, Canada; Uwe M&#xfc;ller, Leipzig University, Germany; Fran&#xe7;ois JMA Meurens, INRA Ecole nationale v&#xe9;t&#xe9;rinaire, agroalimentaire et de l&#x2019;alimentation de Nantes-Atlantique (Oniris), France</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Rafael Frandoloso, <email xlink:href="mailto:rfran@upf.br">rfran@upf.br</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>03</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1145072</elocation-id>
<history>
<date date-type="received">
<day>15</day>
<month>01</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>03</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Baldasso, Guizzo, Dazzi, Paraboni Frandoloso, Feronato, von Berg, Carvalho Guedes, Wilson, Kreutz and Frandoloso</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Baldasso, Guizzo, Dazzi, Paraboni Frandoloso, Feronato, von Berg, Carvalho Guedes, Wilson, Kreutz and Frandoloso</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<italic>Lawsonia intracellularis</italic> is the etiologic agent of porcine proliferative enteropathy (PPE), an inflammatory bowel disease with a major economic impact on the pig industry. The serological diagnosis of PPE can be performed using Blocking or Indirect ELISA, Immunoperoxidase Monolayer Assay (IPMA) and Indirect Fluorescence Antibody Test (IFAT). Here, we designed a most sophisticated immunological method for the detection of porcine anti-<italic>L. intracellularis</italic> IgGs, named Flow Cytometry Antibody Test - FCAT. This assay uses whole, live-attenuated <italic>L. intracellularis</italic> bacteria derived from a commercial vaccine. For the assay, we set up the optimal antigen concentration (10<sup>6</sup> bacterium/assay), primary antibody dilution (1:100), time of incubation (20&#xa0;min), antigen stability (15 days), precision (coefficient of variation - CV &lt; 10%), reproducibility (CV &#x2264; 13%) and Receiver Operating Characteristic (ROC). When using a <italic>cut-off</italic> of &gt;15.15% for FCAT, we determined that it showed a sensitivity of 98.8% and specificity of 100%. The rate of agreement with IPMA was 84.09% with a kappa index of 0.66. FCAT was used to screen 1,000 sera from non-vaccinated pigs housed in 22 different farms and we found that 730 pigs (73%) from 16 farms (72.7%) had <italic>L. intracellularis</italic> IgG. This high prevalence confirms that <italic>L. intracellularis</italic> is endemic on Brazilian pig farms. Finally, we determined that FCAT is an easy to perform diagnostic assay and we would highly recommend it for: i) seroepidemiological studies; ii) evaluation of infection dynamics; and iii) characterization of the humoral response profile induced by vaccines.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Lawsonia intracellularis</italic>
</kwd>
<kwd>Ileitis</kwd>
<kwd>pig</kwd>
<kwd>diagnostic test</kwd>
<kwd>flow cytometry assay</kwd>
<kwd>serological antibody detection</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="43"/>
<page-count count="14"/>
<word-count count="7490"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>
<italic>Lawsonia intracellularis</italic> is an obligate intracellular Gram-negative bacterium that causes porcine proliferative enteropathy (PPE), an enteric disease with a major economic impact on the pig industry (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Pigs infected with <italic>L. intracellularis</italic> can develop two clinical forms of the disease depending on their previous immunological condition and the dose of bacteria ingested (<xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B5">5</xref>). The acute form, known as proliferative hemorrhagic enteropathy (<xref ref-type="bibr" rid="B6">6</xref>), affects mainly adult (&gt; 4 months) animals (replacement gilts; growers) and, although clinically less frequent, it can cause high rates of mortality (up to 50%) (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). The chronic form of PPE, in contrast, known as porcine proliferative enteropathy affects growing pigs (6 &#x2013; 16 weeks of age) which has a low mortality rate, close to 1%, and might cause (but not always) a grey-green, semi-solid to liquid diarrhea (<xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>Although the clinical presentations of the disease are very important, the silent (subclinical) course of the infection is most commonly observed on farms and, in this case, the presence of <italic>L. intracellularis</italic> can be demonstrated only by laboratory diagnosis assays as qPCR (if the bacteria are present) and serology (if the bacteria remain present for several months after infection/exposure) (<xref ref-type="bibr" rid="B10">10</xref>). The distribution of <italic>L. intracellularis</italic> in the global pig production system has been demonstrated and the prevalence of infected herds in Germany (91.7%), Denmark (95.8%), Spain (83.3%), France (79.2%), Netherlands (91.7%), United Kingdom (100%), Brazil (37%), China (77%), Canada (&gt;50%) and Australia (100%) (<xref ref-type="bibr" rid="B10">10</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>) illustrates the epidemiological importance of this microorganism. Now that pig farming is progressively reducing the use of antimicrobials as preventive measure, more prevalence of pathogenic bacteria in herds will be present.</p>
<p>The diagnosis of <italic>L. intracellularis</italic> can be confirmed by different assays, which can be used according to the type of biological sample collected. During post-mortem investigations, histological analysis complemented with Warthin-Starry silver staining (<xref ref-type="bibr" rid="B15">15</xref>), immunohistochemistry (<xref ref-type="bibr" rid="B16">16</xref>), and <italic>in situ</italic> hybridization (<xref ref-type="bibr" rid="B17">17</xref>) can be used to directly detect the bacteria in tissues. During <italic>in vivo</italic> monitoring, qPCR is the best technique to detect and determine the load of <italic>L. intracellularis</italic> in feces (<xref ref-type="bibr" rid="B4">4</xref>). ELISA (<xref ref-type="bibr" rid="B18">18</xref>), immunofluorescence antibody test (IFAT) (<xref ref-type="bibr" rid="B19">19</xref>), and immunoperoxidase monolayer assay (IPMA) (<xref ref-type="bibr" rid="B20">20</xref>) can be used to assess antibodies against the microorganism to establish whether the animals were exposed naturally (infection) or artificially [experimental challenges (controlled infection) and vaccination (Porcilis<sup>&#xae;</sup> Ileitis and Enterisol<sup>&#xae;</sup> Ileitis vaccines)].</p>
<p>Serological diagnosis is an excellent tool for assessing the kinetics of infection, the profile and duration of passive immunity, and the potency and duration of the vaccine-induced antibody response. Although these data can be easily obtained for other pathogens such as porcine circovirus type 2 and Influenza A virus, for which several commercial diagnostic kits with high sensitivity and specificity are available, this is not the case for <italic>L. intracellularis</italic>. For this microorganism, only two commercial ELISA kits (Blocking ELISA - Svanovir<sup>&#xae;</sup> <italic>L. intracellularis</italic>/Ileitis-Ab, Sweden, and Indirect ELISA for research use only - Biostone&#x2122; Animal Health, USA) are available and whose sensitivity (Blocking ELISA) close to 72% is considered low. Furthermore, although it is possible to use IFAT and IPMA techniques for detecting anti-<italic>L. intracellularis</italic> IgG, in practice, few laboratories around the world offer these assays as a service, mainly due to the difficulty of cultivating <italic>L. intracellularis</italic>. Therefore, the use of serology to understand the infection dynamic or general sanitary condition of the farm for <italic>L. intracellularis</italic> is limited.</p>
<p>In order to overcome the limitations described above, in this study we used an innovative strategy to develop a new serological diagnostic test to detect antibodies against <italic>L. intracellularis</italic>. This test, named Flow Cytometry Antibody Test (FCAT), uses a live-attenuated strain of <italic>L. intracellularis</italic> as detecting antigen readily available from a commercial vaccine. FCAT has high sensitivity and specificity, is easy to perform, and can be promptly incorporated into the diagnostic routine of any specialized laboratory around the world.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Statement of institutional animal care</title>
<p>All sera used in this study came from: i) other studies previously approved by the Ethics Committee for the Use of Animals in Research at the Universidade de Passo Fundo (CEUA no. 10/2020, 19/2020 &amp; 20/2020); ii) routine of diagnosis of the AFK Imunotech Laboratory; iii) other studies previously approved by the Ethics Committee for the Use of Animals in Research at the Universidade Federal de Minas Gerais (CEUA n&#xb0; 133/2018, 36/2016).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Antigen</title>
<p>The <italic>in vitro</italic> cultivation of <italic>L. intracellularis</italic> is extremely difficult, which limits the production of this bacterium to few laboratories in the world. Since our objective was to develop a serological assay that could be easily performed in any laboratory, we used the vaccine strain of <italic>L. intracellularis</italic> from Enterisol<sup>&#xae;</sup> Ileitis (Boehringer Ingelheim), a live attenuated vaccine, as a source of antigen. This licensed vaccine is distributed worldwide, and all new batches of live antigen are qualified by the manufacturer, an ideal situation to guarantee antigen quality and ensure repeatability between antigens batches and laboratories that will perform this diagnosis.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Sera samples</title>
<p>A total of 246 serum samples obtained from pigs with different serological condition were used to determine the preliminary <italic>cut-off</italic> values of this flow cytometry antibody test (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>
<bold>, Phase I</bold>). The second set of specimens included 1,200 serum samples collected between 2018 and 2021 from 32 farms located in Southern region of Brazil (Paran&#xe1;, Santa Catarina and Rio Grande do Sul) (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>
<bold>, Phase II</bold>); this panel of sera was used to analyze the ability of the established <italic>cut-off</italic> to identify conventional pigs with or without anti-<italic>L. intracellularis</italic> IgGs.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Description of the sera used in this study.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="left">Sera from</th>
<th valign="middle" rowspan="2" align="center">N&#xb0; of Samples</th>
<th valign="middle" colspan="2" align="center">Serological and molecular status of pigs at the time of blood collection</th>
</tr>
<tr>
<th valign="middle" align="center">IgG anti-<italic>L. intracellularis</italic>
</th>
<th valign="middle" align="center">
<italic>L. intracellularis</italic> excretion (feces)</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="middle" colspan="4" align="left">Phase I &#x2013; Preliminary <italic>cut-off</italic>
</th>
</tr>
<tr>
<td valign="middle" align="left">Conventional pigs</td>
<td valign="middle" align="center">38<sup>A</sup>*</td>
<td valign="middle" align="left">Negative (IPMA)</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">Conventional pigs</td>
<td valign="middle" align="center">40<sup>B</sup>**</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">Specific pathogen free (SPF) pigs</td>
<td valign="middle" align="center">40<sup>B</sup>
</td>
<td valign="middle" align="left">Negative (ELISA)</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">SPF pigs vaccinated with Porcilis<sup>&#xae;</sup> Ileitis - MSD</td>
<td valign="middle" align="center">40<sup>B</sup>
</td>
<td valign="middle" align="left">Positive (ELISA)</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">SPF pigs vaccinated with Enterisol<sup>&#xae;</sup> Ileitis - BI</td>
<td valign="middle" align="center">20<sup>B</sup>
</td>
<td valign="middle" align="left">Positive (ELISA)</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">Conventional pigs experimentally infected pigs with <italic>L. intracellularis</italic>
</td>
<td valign="middle" align="center">20<sup>A</sup>*</td>
<td valign="middle" align="left">Positive (IPMA)</td>
<td valign="middle" align="left">Positive (qPCR)</td>
</tr>
<tr>
<th valign="middle" colspan="4" align="left">Specificity</th>
</tr>
<tr>
<td valign="middle" align="left">SPF pigs vaccinated with <italic>Glaesserella parasuis</italic> (<xref ref-type="bibr" rid="B21">21</xref>)</td>
<td valign="middle" align="center">8<sup>C</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">SPF pigs vaccinated with <italic>Mycoplasma hyopneumoniae</italic> (Safesui Mycoplasma - Ourofino)</td>
<td valign="middle" align="center">8<sup>B</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">SPF pigs vaccinated with <italic>Pasteurella multocida</italic> A (Govaxx<sup>&#xae;</sup> - Vaxxinova)</td>
<td valign="middle" align="center">8<sup>B</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">SPF pigs vaccinated with <italic>Salmonella</italic> choleraesuis (Enterisol<sup>&#xae;</sup> SC-54 - BI)</td>
<td valign="middle" align="center">8<sup>B</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">SPF pigs vaccinated with <italic>Escherichia coli</italic> and <italic>Clostridium perfringes</italic> (Porcilis<sup>&#xae;</sup> Coliclos - MSD)</td>
<td valign="middle" align="center">8<sup>B</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">SPF pigs vaccinated with PCV2 (Porcilis<sup>&#xae;</sup> PCV ID - MSD)</td>
<td valign="middle" align="center">8<sup>B</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<th valign="middle" colspan="4" align="left">Phase II &#x2013; <italic>Cut-off</italic> evaluation</th>
</tr>
<tr>
<td valign="middle" align="left">Non-vaccinated conventional pigs</td>
<td valign="middle" align="center">258<sup>B</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Negative (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">Non-vaccinated conventional pigs</td>
<td valign="middle" align="center">742<sup>B</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">Positive (qPCR)</td>
</tr>
<tr>
<td valign="middle" align="left">Vaccinated (Porcilis<sup>&#xae;</sup> Ileitis, MSD) conventional pigs</td>
<td valign="middle" align="center">200<sup>B</sup>
</td>
<td valign="middle" align="left">NPE</td>
<td valign="middle" align="left">NPE</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Origin of the serum samples: A) Universidade Federal de Minas Gerais, prof. Roberto Guedes. Sera from pigs with 100 &#x2013; 160 days old; B) AFK Imunotech (clinical trials). Sera from pigs with 63 &#x2013; 120 days old; C) Study conducted by Ramos et&#xa0;al. (<xref ref-type="bibr" rid="B21">21</xref>). *) Sera previously titrated by IPMA. **) Sera from 150-day-old gilts from a closed genetic herd, with no clinical history of Ileitis. NPE) Samples not previously evaluated. SPF pigs were negative for the presence of <italic>Glaesserella parasuis</italic>, <italic>Actinobacillus pleuropneumoniae</italic>, <italic>Pasteurella multocida</italic> A &amp; D, <italic>Bordetella bronchispetica</italic>, <italic>Streptococcus suis</italic>, <italic>Mycoplasma hyopneumoniae</italic>, <italic>Lawsonia intracellularis</italic>, Swine Influenza Virus A and PCV2.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Antigen stability</title>
<p>The stability of the reconstituted antigen was evaluated daily for a period of 30 days. Three parameters were analyzed by flow cytometry: i) absolute count of <italic>L. intracellularis</italic>; ii) bacterial morphology; and iii) antigenicity. For the first two analyses, a daily aliquot of the antigen was diluted 1:1,000 in filtered PBS pH 7.4 and acquired in the cytometer. The number of bacteria per microliter of acquired samples was calculated automatically by the cytometer which was equipped with flow sensor used for volumetric measurement. Therefore, to calculate the total number of bacteria per mL of the reconstituted vaccine, we used the following mathematical formula: number of events per &#x3bc;L &#xd7; inverse of the dilution factor (1,000) &#xd7; per 1,000 (to convert &#x3bc;L to mL). The morphometric analysis was conducted analyzing the parameters of Forward Scatter (FSC) vs Side Scatter (SSC) of the daily aliquot of the antigen. For the antigenicity analysis, 3 sera from pigs immunized with the Porcilis<sup>&#xae;</sup> Ileitis vaccine were used; briefly, 10<sup>6</sup> bacteria were incubated into the wells of a 96 well conical-bottom polystyrene plates (cat. # K30-6096V, Olen, China) together with 100 &#xb5;L of porcine serum diluted 1:100 in filtered (0,22 &#xb5;m, cat. # GPWP04700, Millipore, Ireland) PBS pH 7.4 containing 1% bovine serum albumin (cat. # A2153, Sigma-Aldrich, USA) (FACS buffer) for 1 hour at 37&#xb0;C. After three washing steps with 200 &#x3bc;L of FACS buffer (plate centrifuged at 1,200 &#xd7; g for 5&#xa0;min; centrifuge 5810R Eppendorf, Germany), 100 &#x3bc;L of FACS buffer containing 1 &#x3bc;g of Goat anti-Porcine IgG(H+L)-PE (cat. # 6050-09, SouthernBiotech, USA) was added and incubated for 1 hour at 37&#xb0;C. Then, the washing steps were repeated, and the bacterial pellet resuspended in 350 &#xb5;L of PBS for analysis. All parameters were analyzed by Flow Cytometry using a FACSVerse Cytometer (Becton Dickinson, USA) equipped with a 405 nm violet laser, 488 nm blue laser, 640 nm red laser and flow sensor. A total of 100,000 events were acquired in P1 region and analyzed. Each sample was analyzed in triplicate.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Determination of the ideal concentration of <italic>L. intracellularis</italic> for the assay</title>
<p>To determine the optimal amount of antigen that would be used in the assay, three different concentrations (10<sup>5</sup>, 10<sup>6</sup> and 10<sup>7</sup>) of <italic>L. intracellularis</italic> were evaluated. Each concentration was incubated with a panel of sera (n=5) with different titers of anti-<italic>L. intracellularis</italic> IgG as defined previously by the IPMA (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>): i) highly positive sera (titer between 1:960 and 1:1,920); ii) moderately positive sera (titer between 1:120 and 1:480); and iii) weakly positive sera (titer of 1:30). The immunostaining was performed as described above (subsection 2.3) and the ideal bacteria concentration was defined as the smallest number of bacteria that: i) allowed the statistical differentiation of three sera categories and ii) ensured enough bacteria to be analyzed after the washing steps.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Primary antibody working dilution</title>
<p>To define the optimal dilution of the primary antibody (porcine sera) different dilutions of a panel of highly positive (n=5, titer &gt; 960), moderately positive (n=5, titer between 1:120 and 1:480, weakly positive (n=5, titer of 1:30) and negative (n=5) sera were analyzed. The dilutions evaluated were 1:50, 1:100 and 1:200 in a final volume of 100 &#xb5;L. The immunostaining was performed as described above (subsection 2.3).</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Evaluation of the incubation period of primary and secondary antibodies</title>
<p>To investigate the shortest incubation period necessary to guarantee the optimal interaction between the molecules involved in the assay, three incubation periods were evaluated: 60&#xa0;min, 30&#xa0;min and 20&#xa0;min. These periods were evaluated for primary (10 different positive samples) and secondary (Goat Anti-Porcine IgG (H+L)-PE) antibodies. All incubations were performed at 37&#xb0;C. The immunostaining was performed as described above (subsection 2.3).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Enzyme-linked immunosorbent assay - ELISA</title>
<p>A total of 100 samples (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>) were analyzed for the presence of anti-<italic>L. intracellularis</italic> antibodies using a commercial blocking ELISA Kit (SVANOVIR<sup>&#xae;</sup>, Boehringer Ingelheim Svanova, Sweden). The protocol was performed following the manufacturer&#x2019;s recommendations.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Immunoperoxidase monolayer assay</title>
<p>The immunoperoxidase monolayer assay (IPMA) was used to detect porcine anti-<italic>L. intracellularis</italic> IgG. This assay was carried out by the laboratory of Prof. Roberto Guedes (Universidade Federal de Minas Gerais), according to the methodology previously described (<xref ref-type="bibr" rid="B20">20</xref>).</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Flow cytometry antibody test</title>
<p>A total of 10<sup>6</sup> <italic>L. intracellularis</italic> suspended in 200 &#xb5;L was added per well of a 96 well conical bottom polystyrene plates. The plate was centrifuged (3,200 &#xd7; g, 5&#xa0;min) and the bacterial pellet was resuspended in 100 &#xb5;L of porcine serum diluted 1:100 in FACS buffer and incubated at 37&#xb0;C during 20&#xa0;min. After three washing steps with 200 &#x3bc;L of FACS buffer (step of centrifugation at 1,200 &#xd7; g for 5&#xa0;min between washes), 100 &#x3bc;L of FACS buffer containing 1 &#x3bc;g of Goat Anti-Porcine IgG(H+L)-PE was added and incubated for 20&#xa0;min at 37&#xb0;C. Then, the bacteria were washed 3 times, resuspended in 350 &#xb5;L of FACS buffer and transferred into a round-bottom tube (Falcon<sup>&#xae;</sup>, cat. # 352052). A total of 100,000 events were acquired in a FACSVerse cytometer. The bacterial population was initially identified through a dot plot crossing the FSC and SSC parameters; where the study region, designated P1, was established. Subsequently, a second dot plot was created, in this case, crossing the FL-2 (Phycoerythrin, PE) and FL-4 (Allophycocyanin, APC) channels and having P1 as the study region. The events considered positive were those enclosed within the quadrant representative of PE (low right). The results are expressed as the percentage of positive bacteria in relation to the total bacteria contained in the P1 region. The step-by-step execution of this diagnosis as well as the analysis strategy are illustrated in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Quick protocol of flow cytometry antibody test for <italic>Lawsonia intracellularis</italic>. The brief protocol of immunostaining and cytometric analysis for the detection of porcine anti-<italic>L. intracellularis</italic> (Li) IgG. MFI, Mean Fluorescence Intensity. This figure was created with <uri xlink:href="https://biorender.com">BioRender.com</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1145072-g001.tif"/>
</fig>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Receiver operating characteristic</title>
<p>The determination of the <italic>cut-off</italic> was performed using a panel of 198 porcine sera (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>
<bold>)</bold>. Briefly, sera from 78 animals known to be negative for anti-<italic>Lawsonia intracellularis</italic> IgG and molecularly (qPCR) negative for <italic>L. intracellularis</italic> were obtained. We also obtained sera from 40 animals from a genetic nucleus herd with no history of Ileitis; these animals were molecularly negative for <italic>L. intracellularis</italic>; collectively sera from a total of 118 negative animals. We used sera from 80 animals serologically positive for <italic>L. intracellularis</italic>; of these total, 60 SPF pigs were vaccinated (qPCR negative), and 20 were experimentally infected (and consequently qPCR-positive). Therefore, the <italic>cut-off</italic> calculation, performed using the Receiver Operating Characteristic (ROC) Curve, included 118 negative and 80 positive animals. All sera were tested by this new assay and the results were used to generate a Receiver Operating Characteristic (ROC) Curve. The selected <italic>cut-off</italic> was based on the sensitivity and specificity values. The ROC Curve analysis was performed using Graph Pad Prism Software Version 9.2.0.</p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>Specificity</title>
<p>The specificity analysis was conducted to evaluate the ability of this assay to identify IgG specifically to <italic>L. intracellularis</italic>, which is the analyte of interest. The analysis was performed as recommended by Selliah, Eck (<xref ref-type="bibr" rid="B22">22</xref>). Briefly, a panel of 48 sera (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>
<bold>, Specificity)</bold> from SPF pigs immunized with <italic>Glaesserella parasuis</italic> (bacterin prepared with SV7 (<xref ref-type="bibr" rid="B21">21</xref>), n=8), <italic>Mycoplasma hyopneumoniae</italic> (Safesui Mycoplasma, Ourofino, n=8), <italic>Pasteurella multocida</italic> A (Bacterin formulated with a Brazilian clinical strain of <italic>P. multocida</italic> A, <italic>pfhA</italic>
<sup>+</sup>, Vaxxinova, n=8), <italic>Salmonella enterica</italic>, serovar Choleraesuis (Enterisol<sup>&#xae;</sup> SC-54 vaccine, Boehringer Ingelheim, n=8), <italic>Clostridium perfringes</italic> type C and <italic>Escherichia coli</italic> (Porcilis<sup>&#xae;</sup> Coliclos, MSD, n=8) and Porcine circovirus type 2 (Porcilis<sup>&#xae;</sup> PCV ID, MSD, n=8) were assessed using the protocol described in subsection 2.8.</p>
</sec>
<sec id="s2_13">
<label>2.13</label>
<title>Precision and reproducibility</title>
<p>Precision is one of the most critical parameters in flow cytometry assay (<xref ref-type="bibr" rid="B22">22</xref>). In order to know the intra-assay precision (precision), samples from 3 positive pigs (vaccinated with Porcilis<sup>&#xae;</sup> Ileitis) and negative SPF pigs were tested twice under the same conditions by a single analyst. With the values obtained from each sample, the mean and coefficient of variation were calculated. For reproducibility analysis (inter-assay precision) the same samples were analyzed by 2 different analysts on 2 different days. Again, with the values obtained from each sample, the mean and the coefficient of variation were calculated. The accuracy acceptance criterion was established by accepting a coefficient of variation between the analyses of the same analyst or between the analysts of a maximum of 25%.</p>
</sec>
<sec id="s2_14">
<label>2.14</label>
<title>Agreement analysis between FCAT and IPMA techniques</title>
<p>To analyze the level of agreement between the FCAT and IPMA, we used a panel of sera from two experimental groups: G1) pigs (n = 8) immunized with the Porcilis<sup>&#xae;</sup> Ileitis vaccine at 21 days of life and G2) pigs (n = 8) inoculated with PBS. Serum samples were collected prior to vaccination (D0) and at the following post-vaccination times: D7, D14, D21, D28 and D55 contributing to 88 sera for comparative purposes. Agreement analysis (Kappa) was performed as described by Landis and Koch (<xref ref-type="bibr" rid="B23">23</xref>).</p>
</sec>
<sec id="s2_15">
<label>2.15</label>
<title>Statistical analysis</title>
<p>All data were analyzed using GraphPad Prism&#x2122; (GraphPad Software, San Diego, California, USA). One or two-way ANOVA with Tukey&#x2019;s multiple comparisons test were used to assess significance between the different variables analyzed in this study. The specific test used in each analysis, as well as the significance, is indicated in the figure legends.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Antigen stability</title>
<p>
<italic>L. intracellularis</italic> obtained from the attenuated vaccine Enterisol<sup>&#xae;</sup> Ileitis was used as a diagnostic antigen. The antigen used in our study is destined to immunizing pigs and should be immediately used upon reconstitution. In the test designed here, the amount of antigen used in each assay is low and a single reconstituted bottle contains enough antigen to be used along a few weeks. Thus, the stability and quality of the reconstituted and refrigerated (4 &#x2013; 8&#xb0;C) antigen was analyzed daily along a 30 days period. During this time, changes in the morphology of the bacterial population (analyzed in the P1 region) were observed after 15 days of antigen storage (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>); a subpopulation of larger and more complex <italic>L. intracellularis</italic> was clearly detected, which may represent loss of bacteria cell wall integrity. Although we observed morphological changes in the bacterial population, the number of bacteria detected at each time point was similar with no significant reduction at any time (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). The antigenicity analysis revealed that antigen stability follows the same trend as bacteria reconstituted for more than two weeks were significantly more antigenic compared to previous time points (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>), which indicated that storage time alters the antigenic characteristics of the reconstituted antigen; thus, for all assays the reconstituted antigen was used for 15 days only.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Antigen stability analysis. An aliquot of Enterisol<sup>&#xae;</sup> Ileitis vaccine reconstituted and stored at 4-8&#xb0;C was analyzed daily by flow cytometry. The aliquot diluted 1:1,000 was analyzed in triplicate and the mean of <italic>L. intracellularis</italic> absolute count plus standard deviation is shown in &#x201c;<bold>(A)</bold>&#x201d;. The coefficient of variation of each quantification is represented at the foot of the bars. The morphological characteristic of the bacterial population at 4 different times is illustrated in &#x201c;<bold>(B)</bold>&#x201d;. The subpopulation of <italic>L. intracellularis</italic> with greatest size and complexity is indicated with the arrowhead highlighted in red. Statistical comparison was performed using one-way ANOVA with Tukey&#x2019;s multiple comparisons test and no significant (ns) differences were found between the moments compared.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1145072-g002.tif"/>
</fig>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Antigenicity analysis of the reconstituted antigen. This analysis was performed by flow cytometry using sera (n=3) from pigs immunized with the Porcilis<sup>&#xae;</sup> Ileitis vaccine. The results express the percentage of <italic>L. intracellularis</italic> bacteria (total population containing 10<sup>6</sup> bacteria) containing antibodies (IgGs) surface. Statistical comparison was performed using one-way ANOVA with Tukey&#x2019;s multiple comparisons, and statistical differences are represented in the figure. Dot plots showing antigenic differences between time D1 and D30 are highlighted in zoom format within the figure.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1145072-g003.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Determination of the ideal concentration of <italic>L. intracellularis</italic> for the assay</title>
<p>The amount of antigen used in a diagnostic test must be evaluated with two objectives: i) functionally (to ensure maximum resolution of the test) and ii) economically (antigen saving). Taking these premises into account, we analyzed 3 concentrations of antigens (10<sup>5</sup>, 10<sup>6</sup>, and 10<sup>7</sup>) immunostained with 3 categories of sera, weakly, moderately, and highly positive as determined by IPMA. As illustrated in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>, regardless of the bacterial concentration it is possible to differentiate the 3 serum categories, except for the concentration of 10<sup>7</sup>, in which weakly and moderately positive sera could not be statistically differentiated. There is a reduction in the percentage of detection of <italic>L. intracellularis</italic> between concentrations of 10<sup>6</sup> and 10<sup>7</sup>, when using weakly and moderately positive sera (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>). Additionally, we noticed that the number of bacteria acquired from immunostaining using 10<sup>5</sup> bacteria was lower (long acquisition period) compared to 10<sup>6</sup> and 10<sup>7</sup>, indicating that part of the bacteria was lost during the washing steps; therefore, the concentration of 10<sup>6</sup> was defined as the ideal concentration of antigen.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Impact of antigen concentration on anti-<italic>L. intracellularis</italic> IgG detection. In this analysis 3 different concentrations of antigens (10<sup>5</sup>, 10<sup>6</sup> and 10<sup>7</sup>) and 3 different categories of sera (weakly, moderately, and highly positive for <italic>L. intracellularis</italic>) were analyzed by flow cytometry after immunostaining. Statistical comparison was performed using two-way ANOVA with Tukey&#x2019;s multiple comparisons. Statistical differences are indicated in the figure.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1145072-g004.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Assessment of primary antibody dilution</title>
<p>The dilution rate of the serum (primary antibody) is essential in any diagnostic test and should be set to mitigate false positive results, usually associated with polyreactive IgGs. Three serum dilutions were analyzed; 1:50, 1:100 and 1:200. We observed that there was no reduction in the percentage of <italic>L. intracellularis</italic> associated to porcine IgGs between the 1:50 and 1:100 dilutions, regardless of the serum category. On the other hand, the percentage of <italic>L. intracellularis</italic> with associated IgGs was significantly lower (p &lt; 0.0001) when sera diluted 1:200 were used, and the number of sera considered positive (<italic>cut-off</italic> set at 15.15% as described in the section 3.5) at lower dilutions (5/5) decreased when the weakly positive sera category was tested (2/5) (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). Therefore, the dilution of the primary serum was set at 1:100.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Primary antibody dilution and its impact on serology interpretation. In this analysis 3 different dilution (1:50, 1:100 and 1:200) of primary antibody (pig sera) classified in 3 different categories (weakly, moderately, and highly positive for <italic>L. intracellularis</italic>) were analyzed by flow cytometry after immunostaining. Statistical comparison was performed using two-way ANOVA with Tukey&#x2019;s multiple comparisons. Statistical differences are indicated in the figure.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1145072-g005.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Selection of the best antibody incubation time</title>
<p>Evaluating antibody incubation time (primary and secondary) is essential in any diagnostic test under development; in general, it is always recommended to select the shortest time, as long as there are no changes in the final result of the diagnosis. Three incubation times (20, 30 and 60&#xa0;min) for both the primary (pig IgG anti-<italic>L. intracellularis</italic>) and secondary (Goat anti-Porcine IgG-PE) antibody were tested. As illustrated in <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>, the mean percentage of <italic>L. intracellularis</italic> with associated IgGs at the 3 different incubation times was 47.5%, 47.1% and 48.0%; additionally, the same dispersion profile of the results was observed, and no significant differences were found between the analyzed times. In view of these results, an incubation time of 20&#xa0;min was selected for the primary and secondary antibodies.</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Outcome of incubation time on the detection of anti-<italic>L. intracellularis</italic> IgG. A total of 10 pig sera positive for IgG anti-<italic>L. intracellularis</italic> were included in this analysis. Pig sera were incubated for 20, 30 and 60 minutes with 10<sup>6</sup> <italic>L. intracellularis</italic> at 37&#xb0;C. Subsequently, the samples were incubated with the secondary antibody for the same times. Statistical comparison was performed using one-way ANOVA with Tukey&#x2019;s multiple comparisons. No statistical differences (ns) were observed between the different times analyzed.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1145072-g006.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Specificity and sensitivity of the flow cytometry antibody test</title>
<p>Once the definition of all parameters and conditions of the Flow Cytometry Antibody Test (FCAT) was concluded, a wide panel of swine sera was used (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>
<bold>, Phase I</bold>) aiming to find the <italic>cut-off</italic> value capable of truly differentiating a positive from a negative serum sample. For this purpose, a ROC curve analysis was conducted using 118 serum samples negative and 80 serum samples positive to <italic>L. intracellularis</italic> antibodies (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). The ROC curve analysis of the FCAT data generated paired estimates of relative sensitivity and relative specificity at different <italic>cut-off</italic> values. A <italic>cut-off</italic> of 15.15% (percentage of <italic>L. intracellularis</italic> with associated IgG) was recommended; and at this <italic>cut-off</italic> value, the relative sensitivity and specificity estimates were 98.8% [95% confidence interval (CI) = 93.2% to 99.9%] and 100% (95% CI = 96.9% to 100%), respectively. The ROC curve had an Area Under the Curve (AUC) value of 0.9963 (95% CI = 0.99 to 1.0), which indicated a high level of accuracy for this FCAT (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>). Thereafter, using the established <italic>cut-off</italic> value, a second panel consisting of 48 sera (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>
<bold>, Specificity</bold>) was tested on the FCAT. As illustrated in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>, none of the sera reached the <italic>cut-off</italic> of 15.15%; therefore, all sera were considered negative for <italic>L. intracellullaris</italic>. This result demonstrates that there is no cross-reactivity between <italic>L. intracellularis</italic> and <italic>G. parasuis</italic>, <italic>M. hyopneumoniae</italic>, <italic>P. multocida</italic> A, <italic>Salmonella enterica</italic>, serovar Choleraesuis, <italic>E. coli</italic>, <italic>C. perfringes</italic> type C and Porcine circovirus type 2. Finally, a third panel of sera (n=1,200, <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>, <bold>Phase II</bold>) from: i) non-vaccinated conventional pigs [<italic>L. intracellularis</italic> (qPCR) negative feces]; ii) non-vaccinated conventional pigs [feces positive for <italic>L. intracellularis</italic> (qPCR)]; and iii) Vaccinated (Porcilis<sup>&#xae;</sup> Ileitis, MSD) conventional pigs, was evaluated in the FCAT. As shown in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>, all animals vaccinated with the Porcilis<sup>&#xae;</sup> Ileitis vaccine developed antibodies against <italic>L. intracellularis</italic> and were therefore considered positive. Similarly, 85.3% of the animals that were shedding <italic>L. intracellularis</italic> in the feces had anti-<italic>L. intracellularis</italic> IgG at a level higher than the FCAT <italic>cut-off</italic>; and 68.7% of the animals that were not shedding <italic>L. intracellularis</italic> at the time of blood collection had previous contact with <italic>L. intracellularis</italic>.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Basic immunological characteristics of the FCAT method. <bold>(A)</bold> Receiver Operating Characteristic (ROC) analysis. <bold>(B)</bold> Representation of the percentage values (dispersion) of <italic>L. intracellularis</italic> recognition of the samples used to define the <italic>cut-off</italic> of the FCAT test. The sensitivity and specificity of the test using the <italic>cut-off</italic> of &gt; 15.15% are described in the figure. <bold>(C)</bold> FCAT specificity analysis using sera from pigs immunized with other pathogens. <bold>(D)</bold> Analysis of clinical samples collected from pigs with different immunological backgrounds against <italic>L. intracellularis</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1145072-g007.tif"/>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Precision and reproducibility of the FCAT</title>
<p>The precision (intra-assay) and reproducibility (inter-assay) analysis were performed by two different analysts (A and B). As described in the <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>, the coefficient of variation (CV) of the samples analyzed in triplicate by each of the analysts was always less than 10%, indicating that analysts performed the immunostaining and acquisition of samples with precision. Furthermore, when the same samples were repeated by the same analyst on the following day, a CV of less than 10% was again observed. It is important to highlight that the results of immunostaining performed by the two analysts varied little, with the smallest variation being 0.9% and the maximum 13%; these data indicate that FCAT has high accuracy.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Precision and reproducibility analysis of pig serum by different analyst at two different days.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="3" align="left">Day</th>
<th valign="middle" rowspan="3" align="center">Serum</th>
<th valign="middle" colspan="4" align="center">% of <italic>L. intracellularis</italic> detected by pig IgG</th>
</tr>
<tr>
<th valign="middle" colspan="2" align="center">Analyst A</th>
<th valign="middle" colspan="2" align="center">Analyst B</th>
</tr>
<tr>
<th valign="middle" align="center">Mean</th>
<th valign="middle" align="center">%CV</th>
<th valign="middle" align="center">Mean</th>
<th valign="middle" align="center">%CV</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="6" align="left">01</td>
<td valign="middle" align="center">#01</td>
<td valign="middle" align="center">10.3</td>
<td valign="middle" align="center">6.2</td>
<td valign="middle" align="center">11.1</td>
<td valign="middle" align="center">6.0</td>
</tr>
<tr>
<td valign="middle" align="center">#02</td>
<td valign="middle" align="center">12.2</td>
<td valign="middle" align="center">1.2</td>
<td valign="middle" align="center">12.7</td>
<td valign="middle" align="center">3.8</td>
</tr>
<tr>
<td valign="middle" align="center">#03</td>
<td valign="middle" align="center">14.7</td>
<td valign="middle" align="center">2.3</td>
<td valign="middle" align="center">12.8</td>
<td valign="middle" align="center">2.5</td>
</tr>
<tr>
<td valign="middle" align="center">#04</td>
<td valign="middle" align="center">41.4</td>
<td valign="middle" align="center">7.2</td>
<td valign="middle" align="center">39.1</td>
<td valign="middle" align="center">7.1</td>
</tr>
<tr>
<td valign="middle" align="center">#05</td>
<td valign="middle" align="center">36.7</td>
<td valign="middle" align="center">7.2</td>
<td valign="middle" align="center">37.2</td>
<td valign="middle" align="center">4.5</td>
</tr>
<tr>
<td valign="middle" align="center">#06</td>
<td valign="middle" align="center">52.3</td>
<td valign="middle" align="center">3.4</td>
<td valign="middle" align="center">57.5</td>
<td valign="middle" align="center">2.8</td>
</tr>
<tr>
<td valign="middle" rowspan="6" align="left">02</td>
<td valign="middle" align="center">#01</td>
<td valign="middle" align="center">10.6</td>
<td valign="middle" align="center">6.8</td>
<td valign="middle" align="center">10.8</td>
<td valign="middle" align="center">8.3</td>
</tr>
<tr>
<td valign="middle" align="center">#02</td>
<td valign="middle" align="center">11.3</td>
<td valign="middle" align="center">2.5</td>
<td valign="middle" align="center">11.9</td>
<td valign="middle" align="center">4.5</td>
</tr>
<tr>
<td valign="middle" align="center">#03</td>
<td valign="middle" align="center">13.1</td>
<td valign="middle" align="center">3.6</td>
<td valign="middle" align="center">13.4</td>
<td valign="middle" align="center">2.3</td>
</tr>
<tr>
<td valign="middle" align="center">#04</td>
<td valign="middle" align="center">40.0</td>
<td valign="middle" align="center">4.3</td>
<td valign="middle" align="center">40.8</td>
<td valign="middle" align="center">6.9</td>
</tr>
<tr>
<td valign="middle" align="center">#05</td>
<td valign="middle" align="center">39.0</td>
<td valign="middle" align="center">6.2</td>
<td valign="middle" align="center">38.5</td>
<td valign="middle" align="center">4.6</td>
</tr>
<tr>
<td valign="middle" align="center">#06</td>
<td valign="middle" align="center">54.8</td>
<td valign="middle" align="center">3.3</td>
<td valign="middle" align="center">55.4</td>
<td valign="middle" align="center">1.6</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Comparison between FCAT and IPMA techniques</title>
<p>To analyze the level of agreement between FCAT and IPMA, sera collected from two groups of pigs (vaccinated and unvaccinated) at different post-vaccination periods were analyzed by these two methodologies in two different laboratories (FCTA conducted at the Frandoloso&#x2019;s lab and IPMA conducted at Guedes&#x2019;s lab). To avoid any bias, the analysis was blind, and the history of the sera was not revealed to the analysts. As described in <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>, out of the total number of samples tested (n=88), 74 had the same result in both methodologies, which represents a direct agreement of 84.09%. Using all the data (samples with the same and different results according to the technique used) the Kappa index was generated resulting in a general agreement of 0.66 &#xb1; 0.08 (95% CI = 0.50 to 0.82) (<xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>), which represent a substantial agreement taken into consideration the Kappa scale (0 to 1).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Serological evolution of pigs immunized or non-immunized pigs with <italic>Lawsonia intracellularis</italic>.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="3" align="left">Groups</th>
<th valign="middle" rowspan="3" align="center">Assay</th>
<th valign="middle" colspan="6" align="center">Number of positive animals/total number of animals evaluated</th>
</tr>
<tr>
<th valign="middle" colspan="6" align="center">Experimental days</th>
</tr>
<tr>
<th valign="middle" align="center">D0</th>
<th valign="middle" align="center">D7</th>
<th valign="middle" align="center">D14</th>
<th valign="middle" align="center">D21</th>
<th valign="middle" align="center">D35</th>
<th valign="middle" align="center">D55*</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="2" align="left">G1 &#x2013; Vaccinated</td>
<td valign="middle" align="left">FCAT</td>
<td valign="middle" align="center">0/8</td>
<td valign="middle" align="center">4/8</td>
<td valign="middle" align="center">6/8</td>
<td valign="middle" align="center">8/8</td>
<td valign="middle" align="center">8/8</td>
<td valign="middle" align="center">4/4</td>
</tr>
<tr>
<td valign="middle" align="left">IPMA</td>
<td valign="middle" align="center">1/8</td>
<td valign="middle" align="center">4/8</td>
<td valign="middle" align="center">4/8</td>
<td valign="middle" align="center">8/8</td>
<td valign="middle" align="center">8/8</td>
<td valign="middle" align="center">4/4</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">G2 &#x2013; Non-vaccinated</td>
<td valign="middle" align="left">FCAT</td>
<td valign="middle" align="center">0/8</td>
<td valign="middle" align="center">0/8</td>
<td valign="middle" align="center">0/8</td>
<td valign="middle" align="center">0/8</td>
<td valign="middle" align="center">0/8</td>
<td valign="middle" align="center">0/4</td>
</tr>
<tr>
<td valign="middle" align="left">IPMA</td>
<td valign="middle" align="center">0/8</td>
<td valign="middle" align="center">2/8</td>
<td valign="middle" align="center">4/8</td>
<td valign="middle" align="center">1/8</td>
<td valign="middle" align="center">0/8</td>
<td valign="middle" align="center">0/4</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*At D55, only 4 animals from each group were analyzed, since the others were sacrificed at previous moments for the analysis of other parameters (data not shown).</p>
</fn>
<fn><p>The presence of anti-<italic>L. intracellularis</italic> IgG in pig&#x2019;s serum was evaluated by FCAT and IPMA.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Matrix used to calculate the Kappa index.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center"/>
<th valign="middle" colspan="3" align="center">FCAT</th>
<th valign="middle" align="center"/>
</tr>
<tr>
<th valign="middle" align="center"/>
<th valign="middle" align="center"/>
<th valign="middle" align="center">Positive</th>
<th valign="middle" align="center">Negative</th>
<th valign="middle" align="center">Total</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="4" align="left">IPMA</td>
<td valign="middle" align="left">Positive</td>
<td valign="middle" align="center">26</td>
<td valign="middle" align="center">10</td>
<td valign="middle" align="center">36</td>
</tr>
<tr>
<td valign="middle" align="left">Negative</td>
<td valign="middle" align="center">4</td>
<td valign="middle" align="center">48</td>
<td valign="middle" align="center">52</td>
</tr>
<tr>
<td valign="middle" align="left">Total</td>
<td valign="middle" align="center">30</td>
<td valign="middle" align="center">58</td>
<td valign="middle" align="center">
<bold>88</bold>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>The calculation was performed online using the &#x201c;Quantify Agreement with Kappa&#x201d; tool from the GraphPad by Dotmatics website.</p>
</table-wrap-foot>
</table-wrap>
<p>Considering that the pigs used in this experiment were Specific Pathogen Free and kept in a controlled facility (BSL-2) throughout the study, our expectation was that all animals, regardless of the diagnostic technique, would be negative for <italic>L. intracellularis</italic>. As illustrated in <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>, we observed that a considerable number of pigs from group G2 (non-vaccinated) were positive for anti-<italic>L. intracellularis</italic> IgG as determined by the IPMA day (D) 7 (n=2, 25%), D14 (n=4, 50%) and D21 (n=1, 12.5%) post inoculation with PBS (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). We understand that these IPMA results are false positives, and this interpretation is supported by two observations: i) samples collected from the same pigs at days D35 and D55 were negative by IPMA (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>); ii) all sera samples from this group were negative for anti-<italic>L. intracellularis</italic> IgG by FCAT.</p>
<p>The sensitivity to specifically detect the analytical, in our case the anti-<italic>L. intracellularis</italic> IgG during the genesis of humoral response induced by vaccination is one of the most important features. We noticed that both techniques are very similar in terms of sensitivity; however, FCAT standing out slightly over IPMA on D14, at that moment the FCAT classified more animals as positive than the IPMA.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>
<italic>Lawsonia intracellularis</italic> is a complex intracellular bacterium ubiquitously found in the pig production system worldwide (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B24">24</xref>). This microorganism is the causative agent of PPE which is considered one of most important enteric diseases of pigs in the growing and finishing phases. The presence of uncontrolled <italic>L. intracellularis</italic> infection in pigs has significant economic impacts due to its negative effect on daily gain, feed conversion rate and mortality (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>Currently, the control of PPE can be performed satisfactorily by using licensed vaccines, and in this line, three antigen delivery platforms are available to immunize pigs. Boehringer Ingelheim commercializes the Enterisol<sup>&#xae;</sup> Ileitis vaccine, which is based on an attenuated strain of <italic>L. intracellularis</italic> and whose administration is carried out through the drinking water or by directly administration into the oral cavity of piglets. In parallel, MSD Animal Health has two inactivated vaccines, which can be administered intramuscularly (Porcilis<sup>&#xae;</sup> Ileitis &amp; Porcilis<sup>&#xae;</sup> Lawsonia) and intradermally (Porcilis<sup>&#xae;</sup> Lawsonia ID). The effectiveness of these vaccines has already been scientifically demonstrated (<xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B31">31</xref>) and their use in pig production is a valuable tool for the progressive reduction of antimicrobial usage as a measure to prevent this disease (<xref ref-type="bibr" rid="B32">32</xref>). Additionally, it is important to recognize that vaccines applied by the oral and intradermal routes are still scarce in pigs (and in mammals in general). Due to their demonstrated efficacy, they represent two platforms that should be priority for the veterinary pharmaceuticals industry. These vaccines are safe from the point of view of application (without needles, and therefore mitigate iatrogenic transmission of pathogens) and painless, which contemplates one of the premises of animal welfare.</p>
<p>During infection, <italic>L. intracellularis</italic> stimulates B lymphocytes to produce mucosal (IgA) (<xref ref-type="bibr" rid="B33">33</xref>) and systemic antibodies (IgG) (<xref ref-type="bibr" rid="B34">34</xref>). The immunization using inactivated-based vaccines consistently induces systemic IgG (<xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B30">30</xref>), a feature that is also observed in animals immunized with the attenuated vaccine (<xref ref-type="bibr" rid="B34">34</xref>). Therefore, antibodies (IgG) are a valuable marker to demonstrate the circulation of the agent in the farm, or even to monitor the antibody response after the application of vaccines.</p>
<p>Since the negative impact of <italic>L. intracellularis</italic> infection for pig production is unquestionable, in this study we present a new method of serological diagnosis for <italic>L. intracellularis</italic>, named Flow Cytometry Antibody Test. Flow cytometry has been used to quantify the percentage of eukaryotic cells which had taken up or were associated with fluorescent <italic>L. intracellularis</italic> (<xref ref-type="bibr" rid="B35">35</xref>). As described in <xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref>, there are different diagnostic tests available on the market for the detection of anti-<italic>L. intracellularis</italic> IgG, which differ regarding sensitivity, specificity, execution time and complexity. Among these tests, the FCAT stands out in all parameters; the method is highly sensitive (98.8%), specific (100%) and takes approximately only 1:15 hours to run, which represents a time saving compared to Blocking ELISA, Indirect ELISA, IPMA and IFAT of 47%, 8%, 33% and 12%, respectively. Although the specificity of IPMA and FCAT are the same (100%), the sensitivity of the FCAT method (98.8%) is much higher than IPMA (89%), IFAT (91%) and Blocking ELISA (72%) (<xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref>). In practical terms it represents a greater ability to detect truly positive samples even if they contain low levels of antibodies to the bacterium.</p>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Types and main characteristics of available serological assays for <italic>L. intracellularis</italic>.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="left">Characteristics</th>
<th valign="middle" colspan="5" align="center">Immunoassays for <italic>Lawsonia intracellularis</italic>
</th>
</tr>
<tr>
<th valign="middle" align="center">Blocking ELISA</th>
<th valign="middle" align="center">Indirect ELISA</th>
<th valign="middle" align="center">IPMA</th>
<th valign="middle" align="center">IFAT</th>
<th valign="middle" align="center">FCAT</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Sensitivity</td>
<td valign="middle" align="center">72%</td>
<td valign="middle" align="left">NA*</td>
<td valign="middle" align="center">89%</td>
<td valign="middle" align="center">91%</td>
<td valign="middle" align="center">98.8%</td>
</tr>
<tr>
<td valign="middle" align="left">Specificity</td>
<td valign="middle" align="center">93%</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="center">100%</td>
<td valign="middle" align="center">97%</td>
<td valign="middle" align="center">100%</td>
</tr>
<tr>
<td valign="middle" align="left">Time of execution</td>
<td valign="middle" align="center">2:20 h</td>
<td valign="middle" align="left">1:25 h</td>
<td valign="middle" align="center">2:00 h</td>
<td valign="middle" align="center">1:30 h</td>
<td valign="middle" align="center">1:15 h</td>
</tr>
<tr>
<td valign="middle" align="left">Reference</td>
<td valign="middle" align="center">(<xref ref-type="bibr" rid="B18">18</xref>)</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B36">36</xref>)</td>
<td valign="middle" align="center">(<xref ref-type="bibr" rid="B20">20</xref>)</td>
<td valign="middle" align="center">(<xref ref-type="bibr" rid="B37">37</xref>)</td>
<td valign="middle" align="center">This study</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*Not available.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The reason why FCAT is superior to other tests is related to the basic characteristics of the assay, such as: i) live <italic>L. intracellularis</italic> is used in the test (the antigen source for this test is available globally &#x2013; Enterisol<sup>&#xae;</sup> Ileitis, BI); ii) the antigen is not chemically (acetone and methanol) treated during the test [all antigens (protein lipids and saccharides) remain native]; iii) the entire surface of the antigen is accessible to antibodies (increases the chance of antibodies specifically binding to the surface of <italic>L. intracellularis</italic>); and iv) the fluorescence reading is performed automatically by Flow Cytometry Equipment, and therefore, mitigates human errors (e.g. subjective counting) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). In contrast to FCAT, in the case of IPMA and IFAT, the cells are fixed with acetone and methanol, which promotes disruption of the cytoplasmic membrane of infected eukaryotic cells and might reduce the antigenic quality of the antigens (<xref ref-type="bibr" rid="B38">38</xref>) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>). Additionally, in the case of IPMA, as the reading is performed manually with an inverted microscope, and as endogenous cell-derived peroxidases might be present on the assay, some false positive results can be expected (<xref ref-type="bibr" rid="B39">39</xref>). In this line, in our study, when analyzing sera from SPF piglets that were truly negative for <italic>L. intracellularis</italic>, we observed false positive results at four different times by the IPMA technique (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>); and, therefore, considering its biological limitation, the use of IPMA in the certification of negative farms for <italic>L. intracellularis</italic> should be carried out with caution.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Illustration of different serological diagnostic tests for <italic>Lawsonia intracellularis</italic>. <bold>(A)</bold> Flow Cytometry Antibody Test. In this assay, porcine antibodies interact with <italic>L. intracellularis</italic> floating in the well of the plate. The binding of specific antibodies to <italic>L. intracellularis</italic> is demonstrated with a phycoerythrin-conjugated antibody specific for porcine IgG. The test is read on the flow cytometer. <bold>(B)</bold> Immunoperoxidase Monolayer Assay (IPMA) &amp; Indirect Fluorescent Antibody Test (IFAT). In these assays, cells (i.e., McCoy cells) infected with <italic>L. intracellularis</italic> are chemically fixed with acetone-methanol, which promotes a structural change in the cell (cytoplasmic membrane damage, as indicated in figure). This damage is essential for porcine antibodies to interact with <italic>L. intracellularis</italic>. The presence of antibodies bound to <italic>L. intracellularis</italic> is demonstrated by a peroxidase conjugate antibody plus chromogen (3-amino-9-ethyl-carbazole) solution (IPMA). In the case of IFAT, a fluorescein isothiocyanate conjugated antibody is used to reveal the presence of porcine IgG bound to the pathogen. Plates are read under an inverted microscope. <bold>(C)</bold> Blocking ELISA. In this ELISA, a monoclonal antibody bound to the ELISA plate is used to capture <italic>L. intracellularis</italic>. Porcine antibodies compete with the peroxidase-conjugated monoclonal antibody for a specific epitope present on a surface antigen of <italic>L. intracellularis</italic>. The presence of porcine antibodies to <italic>L. intracellularis</italic> is determined by the potential to reduce or inhibit binding of the monoclonal antibody and, therefore, the enzymatic reaction associated with the competing conjugated antibody. <bold>(D)</bold> ELISA Indirect. In this ELISA, <italic>L. intracellularis</italic> is immobilized directly on the ELISA plate; and for this reason, a considerable surface area of the antigen is not accessible to antibodies (physical masking of antigens). Porcine antibodies that recognize <italic>L. intracellularis</italic> are detected with a peroxidase-conjugated anti-porcine IgG antibody. This figure was created with <uri xlink:href="https://biorender.com">BioRender.com</uri>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1145072-g008.tif"/>
</fig>
<p>In addition to the two mentioned techniques, the detection of porcine anti-<italic>L. intracellularis</italic> antibodies can be performed by ELISA. As illustrated in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>, the blocking ELISA is based on i) monoclonal antibody-coated wells for capturing of cell-cultured antigen and ii) utilizes peroxidase-conjugated monoclonal antibodies as competitive antibodies. In this case, one of the disadvantages of this method in relation to FCAT is that the blocking of the conjugated monoclonal antibody is restricted to a single epitope, and therefore, for an animal to be diagnosed as positive, it must produce antibodies against this epitope during infection and/or vaccination. As it is a single epitope, any antigenic variation in this epitope region could generate false negative results. On the other hand, in FCAT, all antibodies generated against the surface antigens of <italic>L. intracellularis</italic> have accessibility to the diagnostic antigen, and therefore, the sensitivity of the technique is greater. The Indirect ELISA (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8D</bold>
</xref>) presents as its main limitation the masking of epitopes, due to the adherence of the bacteria on the plate. An alternative to overcome this limitation is the preparation of biotinylated protein and its immobilization in the correct orientation on streptavidin plates, as described by our group (<xref ref-type="bibr" rid="B40">40</xref>). For the development of the latter ELISA, it is first necessary to characterize an immunogenic, specific, and conserved protein; and efforts in this line need to be carried out, although promising results are already available (<xref ref-type="bibr" rid="B41">41</xref>).</p>
<p>As already mentioned, the main objective of this study was to develop a method of serological diagnosis for <italic>L. intracellularis</italic> that could be widely disseminated among diagnostic laboratories. Our results demonstrated that the objective was achieved and that FCAT is the most sophisticated immunological technique for the detection of anti-<italic>Lawsonia intracellularis</italic> IgGs. It is important to mention that this technique can be used to detect other classes of antibodies, such as systemic monomeric IgA, IgG1 and IgG2, as well as those associated with the ileum mucosa (data not shown). For this purpose, it is necessary to use specific antibodies (mouse anti-Pig IgG1, clone K139 3C8; mouse anti-Pig IgG2, clone K68 Ig2; mouse anti-Pig IgA, clone K61 1B4, Bio-Rad). The flexibility of FCAT is ideal for studying the immunological profile of licensed vaccines as well as vaccines under development against <italic>L. intracellularis</italic>. Furthermore, as described in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>, the FCAT is highly accurate, and comparison of precision (intra-assay) and reproducibility (inter-assay) parameters of the other techniques is not available, which makes it difficult to predict the results obtained by the other methods when performed in different laboratories.</p>
<p>A limitation of FCTA, like ELISA, IPMA and IFAT is that it is not possible to differentiate, based on the presence of systemic IgG, vaccinated animals from those naturally infected with <italic>L. intracellularis</italic>. Additionally, one disadvantage of FCAT relative to other diagnostic techniques is the need for the diagnostic laboratory to have a flow cytometer instrument, which is more expensive than an ELISA reader (for the ELISA technique) or a microscope (for the IPMA and IFAT techniques). However, what may be considered expensive today may become affordable in the medium term (such as the situation with polymerase chain reaction machines for example).</p>
<p>We recognize that we have taken an important step towards improving <italic>L. intracellularis</italic> diagnosis, but future studies need to be carried out to develop, on an industrial scale, the other reagents for this diagnosis, such as positive and negative control sera, and conjugated secondary antibodies, which will increase the repeatability of the results and avoid any variations related to the quality and specificity of the commercial reagents (controls and secondary antibodies).</p>
<p>
<italic>L. intracellularis</italic>, in addition to produce Ileitis in pigs, also causes an intestinal disease in horses called equine proliferative enteropathy (EPE), which cases have been increasing in the last few years, especially in post-weaning foals and occasionally in adult horses (<xref ref-type="bibr" rid="B42">42</xref>). Although the presumptive diagnosis of EPE can be established based on age of the affected animal, clinical signs, and imaging (ultrasonographic evaluation), the confirmation of infection needs to be conducted <italic>in vitro</italic> using molecular or serological techniques. In this scenario, although in this study we did not evaluate FCAT to analyze equine serum, we can speculate, based on existing data on the use of IPMA for the detection of anti-<italic>L. intracellularis</italic> (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B43">43</xref>), that FCAT has a high potential to work for horses. In this case, future studies need to be carried out to demonstrate the application of this technique in this animal species.</p>
<p>Finally, using the FCAT we analyzed the prevalence of circulating antibodies in a total of 1,000 pigs not vaccinated against <italic>L. intracellularis</italic> from 22 different farms located in 8 Brazilian states. As illustrated in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>, a total of 730 pigs were found to be positive for anti-<italic>Lawsonia intracellularis</italic> IgG; these sera were from animals of 16 different farms (72.7%) and indicates a high prevalence of <italic>L. intracellularis</italic> in Brazilian pig farms. The national prevalence found here is higher than those previously reported in the state of Minas Gerais (37%) (<xref ref-type="bibr" rid="B14">14</xref>), which is the fourth main pig producer region of Brazil. Therefore, our results suggest that Brazil is an endemic country for <italic>L. intracellularis</italic>, and that producers should implement biological strategies (vaccines) to mitigate the economic losses caused by this pathogen. Future seroepidemiological studies using the FCAT are needed to better estimate the impact of <italic>L. intracellularis</italic> on Brazilian pig herds.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by Ethics Committee for the Use of Animals in Research at the University of Passo Fundo (CEUA no. 10/2020, 19/2020 &amp; 20/2020). Ethics Committee for the Use of Animals in Research at the Federal University of Minas Gerais (CEUA n&#xb0; 133/2018. 36/2016).</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>Conceived and designed the experiments: RF. Performed the experiments: DZB, JAG, and GCPF. Contributed reagents/materials/analysis tools: RF, LCK, CF, and RMCG. Wrote the paper: DZB, RF, and LCK. Critical review and editing of the manuscript: RMCG, HLW, and SV. All authors discussed the results and commented on the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This study was funded by MSD Animal Health. The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>DB was supported by CAPES &#x2013; Brazilian Federal Agency for Support and Evaluation of Graduate Education within the Ministry of Education of Brazil. LK and RC have a research fellowship from CNPq.</p>
</ack>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>Authors CF and SV were employed by company Merck Sharp &amp; Dohme (MSD) Animal Health.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins M</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Advances in ileitis control, diagnosis, epidemiology and the economic impacts of disease in commercial pig herds</article-title>. <source>Agriculture.</source> (<year>2013</year>) <volume>3</volume>:<page-range>536&#x2013;55</page-range>. doi: <pub-id pub-id-type="doi">10.3390/agriculture3030536</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holyoake</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Mullan</surname> <given-names>BP</given-names>
</name>
<name>
<surname>Cutler</surname> <given-names>RS</given-names>
</name>
</person-group>. <article-title>Simulation of the economic impact of proliferative enteritis on pig production in Australia</article-title>. <source>Aust Vet J</source> (<year>1996</year>) <volume>73</volume>(<issue>3</issue>):<fpage>89</fpage>&#x2013;<lpage>92</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1751-0813.1996.tb09983.x</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Love</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Re-challenge of pigs following recovery from proliferative enteropathy</article-title>. <source>Vet Microbiol</source> (<year>2007</year>) <volume>120</volume>(<issue>3-4</issue>):<page-range>381&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2006.11.004</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collins</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Barchia</surname> <given-names>IM</given-names>
</name>
</person-group>. <article-title>The critical threshold of <italic>Lawsonia intracelullaris</italic> in pig faeces that causes reduced average daily weight gains in experimentally challenged pigs</article-title>. <source>Vet Microbiol</source> (<year>2014</year>) <volume>168</volume>(<issue>2-4</issue>):<page-range>455&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2013.12.003</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guedes</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Winkelman</surname> <given-names>NL</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Relationship between the severity of porcine proliferative enteropathy and the infectious dose of <italic>Lawsonia intracelullaris</italic>
</article-title>. <source>Vet Rec</source> (<year>2003</year>) <volume>153</volume>(<issue>14</issue>):<page-range>432&#x2013;3</page-range>. doi: <pub-id pub-id-type="doi">10.1136/vr.153.14.432</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawson</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Rowland</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fraser</surname> <given-names>G</given-names>
</name>
<name>
<surname>McCartney</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Proliferative haemorrhagic enteropathy</article-title>. <source>Res Vet Sci</source> (<year>1979</year>) <volume>27</volume>(<issue>1</issue>):<fpage>46</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0034-5288(18)32858-3</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rowland</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Rowntree</surname> <given-names>PG</given-names>
</name>
</person-group>. <article-title>A haemorrhagic bowel syndrome associated with intestinal adenomatosis in the pig</article-title>. <source>Vet Rec</source> (<year>1972</year>) <volume>91</volume>(<issue>10</issue>):<page-range>235&#x2013;41</page-range>. doi: <pub-id pub-id-type="doi">10.1136/vr.91.10.235</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Love</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Pathology of proliferative haemorrhagic enteropathy in pigs</article-title>. <source>Vet Pathol</source> (<year>1979</year>) <volume>16</volume>(<issue>1</issue>):<page-range>41&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1177/030098587901600104</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lawson</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Proliferative enteropathy</article-title>. <source>J Comp Pathol</source> (<year>2000</year>) <volume>122</volume>(<issue>2-3</issue>):<fpage>77</fpage>&#x2013;<lpage>100</lpage>. doi: <pub-id pub-id-type="doi">10.1053/jcpa.1999.0347</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname> <given-names>M</given-names>
</name>
<name>
<surname>Crienen</surname> <given-names>A</given-names>
</name>
<name>
<surname>Swam</surname> <given-names>H</given-names>
</name>
<name>
<surname>von Berg</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jolie</surname> <given-names>R</given-names>
</name>
<name>
<surname>Nathues</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Prevalence of <italic>Lawsonia intracellularis</italic> in pig herds in different European countries</article-title>. <source>Porcine Health Manage</source> (<year>2019</year>) <volume>5</volume>:<fpage>31</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40813-019-0137-6</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ling</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>D</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Heegaard</surname> <given-names>PM</given-names>
</name>
<name>
<surname>He</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Seroprevalence of <italic>Lawsonia intracellularis</italic> antibodies in intensive pig farms in China</article-title>. <source>BMC Vet Res</source> (<year>2014</year>) <volume>10</volume>:<fpage>100</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1746-6148-10-100</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paradis</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Gottschalk</surname> <given-names>M</given-names>
</name>
<name>
<surname>Rajic</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ravel</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Aramini</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Seroprevalence of <italic>Lawsonia intracellularis</italic> in different swine populations in 3 provinces in Canada</article-title>. <source>Can Vet J</source> (<year>2007</year>) <volume>48</volume>(<issue>1</issue>):<fpage>57</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.4141/cjas68-008</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holyoake</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Emery</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gonsalves</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dona hoo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Collins</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Prevalence of antibodies to <italic>Lawsonia intracellularis</italic> in pig herds in Australia</article-title>. <source>Aust Vet J</source> (<year>2010</year>) <volume>88</volume>(<issue>5</issue>):<page-range>186&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1111/j.1751-0813.2010.00558.x</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Resende</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Gabardo Mde</surname> <given-names>P</given-names>
</name>
<name>
<surname>Haddad</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Lobato</surname> <given-names>ZI</given-names>
</name>
<name>
<surname>Guedes</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Serological profile, seroprevalence and risk factors related to <italic>Lawsonia intracellularis</italic> infection in swine herds from minas gerais state, Brazil</article-title>. <source>BMC Vet Res</source> (<year>2015</year>) <volume>11</volume>:<fpage>306</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12917-015-0618-z</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huerta</surname> <given-names>B</given-names>
</name>
<name>
<surname>Arenas</surname> <given-names>A</given-names>
</name>
<name>
<surname>Carrasco</surname> <given-names>L</given-names>
</name>
<name>
<surname>Maldonado</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tarradas</surname> <given-names>C</given-names>
</name>
<name>
<surname>Carbonero</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparison of diagnostic techniques for porcine proliferative enteropathy (<italic>Lawsonia intracellularis</italic> infection)</article-title>. <source>J Comp Pathol</source> (<year>2003</year>) <volume>129</volume>(<issue>2-3</issue>):<page-range>179&#x2013;85</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9975(03)00030-6</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szczotka</surname> <given-names>A</given-names>
</name>
<name>
<surname>Stadejek</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zmudzki</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nowak</surname> <given-names>A</given-names>
</name>
<name>
<surname>Osinski</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Pejsak</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Immunohistochemical detection of <italic>Lawsonia intracellularis</italic> in tissue sections from pigs</article-title>. <source>Pol J Vet Sci</source> (<year>2011</year>) <volume>14</volume>(<issue>4</issue>):<page-range>531&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.2478/v10181-011-0079-7</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Boesen</surname> <given-names>HT</given-names>
</name>
<name>
<surname>Vigre</surname> <given-names>H</given-names>
</name>
<name>
<surname>Boye</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Detection of <italic>Lawsonia intracellularis</italic> in formalin-fixed porcine intestinal tissue samples: Comparison of immunofluorescence and in-situ hybridization, and evaluation of the effects of controlled autolysis</article-title>. <source>J Comp Pathol</source> (<year>2010</year>) <volume>142</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jcpa.2009.04.001</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wallgren</surname> <given-names>P</given-names>
</name>
<name>
<surname>Nordengrahn</surname> <given-names>A</given-names>
</name>
<name>
<surname>Merza</surname> <given-names>M</given-names>
</name>
<name>
<surname>Emanuelson</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>Evaluation of a blocking ELISA for the detection of antibodies against <italic>Lawsonia intracellularis</italic> in pig sera</article-title>. <source>Acta Vet Scand</source> (<year>2011</year>) <volume>53</volume>:<fpage>23</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1751-0147-53-23</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guedes</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Preparation and characterization of polyclonal and monoclonal antibodies against <italic>Lawsonia intracellularis</italic>
</article-title>. <source>J Vet Diagn Invest</source> (<year>2003</year>) <volume>15</volume>(<issue>5</issue>):<page-range>438&#x2013;46</page-range>. doi: <pub-id pub-id-type="doi">10.1177/104063870301500506</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guedes</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Deen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Winkelman</surname> <given-names>NL</given-names>
</name>
</person-group>. <article-title>Validation of an immunoperoxidase monolayer assay as a serologic test for porcine proliferative enteropathy</article-title>. <source>J Vet Diagn Invest</source> (<year>2002</year>) <volume>14</volume>(<issue>6</issue>):<page-range>528&#x2013;30</page-range>. doi: <pub-id pub-id-type="doi">10.1177/104063870201400618</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramos Prigol</surname> <given-names>S</given-names>
</name>
<name>
<surname>Klein</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chaudhuri</surname> <given-names>S</given-names>
</name>
<name>
<surname>Paraboni Frandoloso</surname> <given-names>G</given-names>
</name>
<name>
<surname>Guizzo</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Gutierrez Martin</surname> <given-names>CB</given-names>
</name>
<etal/>
</person-group>. <article-title>TbpB<sup>(Y167A)</sup>-based vaccine can protect pigs against glasser's disease triggered by <italic>Glaesserella parasuis</italic> SV7 expressing TbpB cluster I</article-title>. <source>Pathogens</source> (<year>2022</year>) <volume>11</volume>(<issue>7</issue>)<fpage>:766</fpage>. doi: <pub-id pub-id-type="doi">10.3390/pathogens11070766</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selliah</surname> <given-names>N</given-names>
</name>
<name>
<surname>Eck</surname> <given-names>S</given-names>
</name>
<name>
<surname>Green</surname> <given-names>C</given-names>
</name>
<name>
<surname>Oldaker</surname> <given-names>T</given-names>
</name>
<name>
<surname>Stewart</surname> <given-names>J</given-names>
</name>
<name>
<surname>Vitaliti</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Flow cytometry method validation protocols</article-title>. <source>Curr Protoc Cytom</source> (<year>2019</year>) <volume>87</volume>(<issue>1</issue>):<elocation-id>e53</elocation-id>. doi: <pub-id pub-id-type="doi">10.1002/cpcy.53</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landis</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Koch</surname> <given-names>GG</given-names>
</name>
</person-group>. <article-title>The measurement of observer agreement for categorical data</article-title>. <source>Biometrics.</source> (<year>1977</year>) <volume>33</volume>(<issue>1</issue>):<page-range>159&#x2013;74</page-range>. doi: <pub-id pub-id-type="doi">10.2307/2529310</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Dazzi</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Baldasso</surname> <given-names>D</given-names>
</name>
<name>
<surname>Frandoloso</surname> <given-names>GP</given-names>
</name>
<name>
<surname>Kreutz</surname> <given-names>LC RF</given-names>
</name>
</person-group>. <source>Brazilian Growing and finishing pig farms are endemic for Lawsonia intracellularis IPVS2022</source>. (<publisher-loc>Rio de Janeiro, Brazil</publisher-loc>: <publisher-name>The International Pig Veterinary Society - IPVS</publisher-name>) (<year>2022</year>).</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jensen</surname> <given-names>HM</given-names>
</name>
</person-group>. <article-title>Health management with reduced antibiotic use - experiences of a Danish pig vet</article-title>. <source>Anim Biotechnol</source> (<year>2006</year>) <volume>17</volume>(<issue>2</issue>):<page-range>189&#x2013;94</page-range>. doi: <pub-id pub-id-type="doi">10.1080/10495390600957142</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McOrist</surname> <given-names>S</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Green</surname> <given-names>LE</given-names>
</name>
</person-group>. <article-title>Estimate of direct financial losses due to porcine proliferative enteropathy</article-title>. <source>Vet Rec</source> (<year>1997</year>) <volume>140</volume>(<issue>22</issue>):<page-range>579&#x2013;81</page-range>. doi: <pub-id pub-id-type="doi">10.1136/vr.140.22.579</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobson</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fellstrom</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jensen-Waern</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Porcine proliferative enteropathy: An important disease with questions remaining to be solved</article-title>. <source>Vet J</source> (<year>2010</year>) <volume>184</volume>(<issue>3</issue>):<page-range>264&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.tvjl.2009.05.010</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roerink</surname> <given-names>F</given-names>
</name>
<name>
<surname>Morgan</surname> <given-names>CL</given-names>
</name>
<name>
<surname>Knetter</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Passat</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Archibald</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Ait-Ali</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>A novel inactivated vaccine against <italic>Lawsonia intracellularis</italic> induces rapid induction of humoral immunity, reduction of bacterial shedding and provides robust gut barrier function</article-title>. <source>Vaccine.</source> (<year>2018</year>) <volume>36</volume>(<issue>11</issue>):<page-range>1500&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2017.12.049</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname> <given-names>AAC</given-names>
</name>
<name>
<surname>Harks</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hazenberg</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hoeijmakers</surname> <given-names>MJH</given-names>
</name>
<name>
<surname>Nell</surname> <given-names>T</given-names>
</name>
<name>
<surname>Pel</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Efficacy of a novel inactivated <italic>Lawsonia intracellularis</italic> vaccine in pigs against experimental infection and under field conditions</article-title>. <source>Vaccine.</source> (<year>2019</year>) <volume>37</volume>(<issue>15</issue>):<page-range>2149&#x2013;57</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.02.067</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname> <given-names>AAC</given-names>
</name>
<name>
<surname>Harks</surname> <given-names>F</given-names>
</name>
<name>
<surname>Pauwels</surname> <given-names>R</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Holtslag</surname> <given-names>H</given-names>
</name>
<name>
<surname>Pel</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Efficacy of a novel intradermal <italic>Lawsonia intracellularis</italic> vaccine in pigs against experimental infection and under field conditions</article-title>. <source>Porcine Health Manage</source> (<year>2020</year>) <volume>6</volume>:<fpage>25</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40813-020-00164-0</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leite</surname> <given-names>FLL</given-names>
</name>
<name>
<surname>Singer</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Ward</surname> <given-names>T</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Isaacson</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>Vaccination against <italic>Lawsonia intracellularis</italic> decreases shedding of <italic>Salmonella enterica</italic> serovar Typhimurium in Co-infected pigs and alters the gut microbiome</article-title>. <source>Sci Rep</source> (<year>2018</year>) <volume>8</volume>(<issue>1</issue>):<fpage>2857</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-21255-7</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karuppannan</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Opriessnig</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>
<italic>Lawsonia intracellularis</italic>: Revisiting the disease ecology and control of this fastidious pathogen in pigs</article-title>. <source>Front Vet Sci</source> (<year>2018</year>) <volume>5</volume>:<elocation-id>181</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fvets.2018.00181</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guedes</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Evidence of cell-mediated immune response and specific local mucosal immunoglobulin (Ig) a production against <italic>Lawsonia intracellularis</italic> in experimentally infected swine</article-title>. <source>Can J Vet Res</source> (<year>2010</year>) <volume>74</volume>(<issue>2</issue>):<fpage>97</fpage>&#x2013;<lpage>101</lpage>.</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guedes</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Onset and duration of fecal shedding, cell-mediated and humoral immune responses in pigs after challenge with a pathogenic isolate or attenuated vaccine strain of <italic>Lawsonia intracellularis</italic>
</article-title>. <source>Vet Microbiol</source> (<year>2003</year>) <volume>91</volume>(<issue>2-3</issue>):<page-range>135&#x2013;45</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0378-1135(02)00301-2</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obradovic</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pasternak</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>HL</given-names>
</name>
</person-group>. <article-title>Use of flow cytometry and PCR analysis to detect 5-carboxyfluoroscein-stained obligate intracellular bacteria <italic>Lawsonia intracellularis</italic> invasion of McCoy cells</article-title>. <source>J Microbiol Methods</source> (<year>2016</year>) <volume>126</volume>:<page-range>60&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.mimet.2016.04.015</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="book">
<article-title>Biostone</article-title>. In: <source>AsurDx&#x2122; Lawsonia intracellularis antibody test</source>. (<publisher-loc>Southlake, Texas, USA</publisher-loc>, <publisher-name>BioStone Animal Health</publisher-name>) (<year>2022</year>) Available at: <uri xlink:href="https://biostoneah.com/how-to-order/">https://biostoneah.com/how-to-order/</uri>.</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knittel</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Jordan</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Schwartz</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Janke</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Roof</surname> <given-names>MB</given-names>
</name>
<name>
<surname>McOrist</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluation of antemortem polymerase chain reaction and serologic methods for detection of <italic>Lawsonia intracellularis</italic>-exposed pigs</article-title>. <source>Am J Vet Res</source> (<year>1998</year>) <volume>59</volume>(<issue>6</issue>):<page-range>722&#x2013;6</page-range>.</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Optimization of fixation methods for observation of bacterial cell morphology and surface ultrastructures by atomic force microscopy</article-title>. <source>Appl Microbiol Biotechnol</source> (<year>2011</year>) <volume>92</volume>(<issue>2</issue>):<page-range>381&#x2013;92</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00253-011-3551-5</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guedes</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Winkelman</surname> <given-names>NL</given-names>
</name>
<name>
<surname>Mackie-Nuss</surname> <given-names>RA</given-names>
</name>
</person-group>. <article-title>A comparative study of an indirect fluorescent antibody test and an immunoperoxidase monolayer assay for the diagnosis of porcine proliferative enteropathy</article-title>. <source>J Vet Diagn Invest</source> (<year>2002</year>) <volume>14</volume>(<issue>5</issue>):<page-range>420&#x2013;3</page-range>. doi: <pub-id pub-id-type="doi">10.1177/104063870201400512</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Frandoloso</surname> <given-names>R</given-names>
</name>
<name>
<surname>Schryvers</surname> <given-names>AB</given-names>
</name>
</person-group>. <article-title>Structure-based antigen design: Targeting transferrin receptors to prevent respiratory and systemic disease of swine</article-title>. In: <source>International pig veterinary society congress &#x2013; IPVS2020</source>. <publisher-loc>Rio de Janeiro</publisher-loc>: <publisher-name>IPVS2020</publisher-name> (<year>2020</year>).</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watarai</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yamato</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Horiuchi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S</given-names>
</name>
<name>
<surname>Omata</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shirahata</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Enzyme-linked immunosorbent assay to detect <italic>Lawsonia intracellularis</italic> in rabbits with proliferative enteropathy</article-title>. <source>J Vet Med Sci</source> (<year>2004</year>) <volume>66</volume>(<issue>6</issue>):<page-range>735&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1292/jvms.66.735</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pusterla</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gebhart</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>
<italic>Lawsonia intracellularis</italic> infection and proliferative enteropathy in foals</article-title>. <source>Vet Microbiol</source> (<year>2013</year>) <volume>167</volume>(<issue>1-2</issue>):<fpage>34</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.vetmic.2013.06.017</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guimaraes-Ladeira</surname> <given-names>CV</given-names>
</name>
<name>
<surname>Palhares</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Ramirez</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Guedes</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Faecal shedding and serological cross-sectional study of <italic>Lawsonia intracellularis</italic> in horses in the state of minas gerais, Brazil</article-title>. <source>Equine Vet J</source> (<year>2009</year>) <volume>41</volume>(<issue>6</issue>):<page-range>593&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.2746/042516409X407639</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>